Phase II Study Evaluating Transarterial Chemoembolization (TACE) in Combination With Sorafenib for the Treatment of Advanced Hepatocellular Carcinoma (HCC).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms SOCRATES
- 07 Jun 2012 Biomarkers information updated
- 06 Jun 2012 Last checked against ClinicalTrials.gov record.
- 06 Jun 2012 Actual patient number is 43 as reported by ClinicalTrials.gov.